The Fox Chase Chemical Diversity Center, Inc. (FCCDC)

 

The Fox Chase Chemical Diversity Center Announces that it Has Been Awarded a Phase I STTR Grant Together With Prof. Harvey Rubin of the University of Pennsylvania, “New Therapeutics for the Treatment of Acinetobactor baumannii Infections,” Totaling $300,000

 

Doylestown, PA. August 23, 2013- FCCDC is pleased to announce that it has been awarded a Phase I STTR grant together with Prof. Harvey Rubin of the University of Pennsylvania (1R41AI108196-01), “New Therapeutics for the Treatment of Acinetobactor baumannii Infections” ($300,000).